Evidence-based outcomes for patients with non-small cell lung cancer undergoing resection

Seminars in Respiratory and Critical Care Medicine

Volumn 21, Issue 5, 2000, Pages 433-441

  Rusch, V W ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Evidence based outcomes; Surgery for non small cell lung cancer

Indexed keywords

CANCER STAGING; EVIDENCE BASED MEDICINE; HUMAN; LUNG NON SMALL CELL CANCER; LUNG RESECTION; PATIENT SELECTION; PRIORITY JOURNAL; REVIEW; SURGICAL MORTALITY; TREATMENT OUTCOME;

EID: 0033809362     PISSN: 10693424     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2000-9406     Document Type: Review

References (80)

1. Modern thirty-day operative mortality for surgical resections in lung cancer
2. Complications of surgery in the treatment of carcinoma of the lung
3. Thirty-day operative mortality for thoracotomy in lung cancer
4. Pulmonary resection for lung cancer in octogenarians
5. Indications, risks, and results of completion pneumonectomy
6. Completion pneumonectomy: Analysis of operative mortality, and survival
7. Current operative morbidity associated with elective surgical resection for lung cancer
8. Prospective analysis of pneumonectomy: Risk factors for major morbidity and cardiac dysrhythmias
9. Early complications in surgical treatment of lung cancer: A prospective, multicenter study
10. Impact of irradiation technique and tumor extent in rumor control and survival of patients with unresectable non-oat cell carcinoma of the lung. Report by the radiation therapy oncology group
11. The curative treatment by radiotherapy alone of stage I non-small cell carcinoma of the lung
12. The 'incomplete' resection
13. Importance of microscopic residual disease at the bronchial margin after resection for non-small cell carcinoma of the lung
14. Significance of extramucosal residual tumor at the bronchial resection margin
15. Prognosis and survival in resected lung carcinoma based on the new international staging system
16. Lymph node mapping and curability at various levels of metastasis in resected lung cancer
17. The lung cancer study group postoperative T1 N0 non-small cell lung cancer
18. Prognostic factors in patients with resected stage I non-small cell lung cancer. A report from the lung cancer study group
19. Prognostic factors obtained by a pathologic examination in completely resected non-small cell lung cancer. An analysis in each pathologic stage
20. Surgical results and prognostic factors of pathologic N1 disease in non-small-cell carcinoma of the lung. Significance of N1 level: Lobar or hilar nodes
21. Survival after resection of stage II non-small cell lung cancer
22. The lung cancer study group cancer recurrence after resection T1 NO non-small cell lung cancer
23. The Ludwig lung cancer study group patterns of failure in patients with resected stage I and II non-small-cell carcinoma of the lung
24. Prognostic implications of histopathologic subtyping in patients with surgically treated stage I or II adenocarcinoma of the lung
25. Survival determinants in extensive-stage non-small-cell lung cancer: The southwest oncology group experience
26. Longer survival after resection of non-small cell lung cancer in Japanese women
27. Tumor angiogenesis as a prognostic marker in operable non-small cell lung cancer
28. Blood vessel and lymphatic vesel invasion in resected non-small cell lung carcinoma. Correlation with TNM stage and disease free and overall survival
29. Blood vessel invasion is a major prognostic factor in resected non-small cell lung cancer
30. Mode of spread in the early phase of lymphatic metastasis in non-small cell lung cancer: Significance of nodal micrometastasis
31. Tumor cells in intraoperative pleural lavage. An indicator for the poor prognosis of bronchogenic carcinoma
32. K-ras oncogene activation as a prognostic marker in adenocarcinoma of the lung
33. Clinical significance of ras oncogene activation in human lung cancer
34. Immunocytochemical markers in stage I lung cancer: Relevance to prognosis
35. Molecular pathologic substaging in 244 stage I non-small cell lung cancer patients: Clinical implications
36. Malignant disease appearing late after operation for T1 N0 non-small-cell lung cancer
37. The first site of recurrence after complete resection in non-small-cell carcinoma of the lung. Comparison between pN0 disease and pN2 disease
38. Survival following resection for second primary bronchogenic carcinoma
39. Multiple primary lung cancers. Results of surgical treatment
40. Results of resection in non-oat cell carcinoma of the lung with mediastinal lymph node metastases
41. The prognosis of surgically resected N2 non-small cell lung cancer: The importance of clinical N status
42. Significance of metastatic disease in subaortic lymph nodes
43. Chest wall invasion in carcinoma of the lung. Therapeutic and prognostic implications
44. Extent of chest wall invasion and survival in patients with lung cancer
45. Surgical treatment of 125 patients with non-small cell lung cancer and chest wall involvement
46. Chest wall tumors. Experience with 100 consecutive patients
47. Surgery, and the management of peripheral lung tumors adherent to the parietal pleura
48. Hemivertebrectomy for apical chest tumors: Is risk justified by the outcome?
49. Pancoast describes suprior pulmonary sulcus tumor
50. Treatment of the superior sulcus tumor by irradiation followed by resection
51. Superior sulcus lung tumors: Impact of local control on survival
52. Factors determining outcome after surgical resection of T3 and T4 lung cancers of the superior sulcus
53. Extended resection of bronchogenic carcinoma in the superior pulmonary sulcus
54. Anterior transcervical-thoracic approach for radical resection of lung tumors invading the thoracic inlet
55. Transmanubrial approach with antero-lateral thoracotomy for apical chest tumor
56. The clamshell incision. An improved approach to bilateral pulmonary and mediastinal tumor
57. Management of non-small cell lung cancer with direct mediastinal involvement
58. Results of surgical treatment of patients with T3 non-small cell lung cancer
59. Results of resection of T3 non-small cell lung cancer invading the mediastinum or main bronchus
60. Resection of lung cancer invading the diaphragm
61. Results of sleeve lobectomy for bronchogenic carcinoma in 101 patients
62. Survival related to nodal status after sleeve resection for lung cancer
63. Favorable results after sleeve lobectomy or bronchoplasty for bronchial malignancies
64. Sleeve pneumonectomy
65. Clinical experience with carinal resection
66. T4 lung tumors with infiltration of the thoracic aorta: Is an operation reasonable?
67. Induction chemotherapy for T4 centrally located non-small cell lung cancer
68. Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for stages IIIA (N2) and IIIB non-small cell lung cancer: Mature results of southwest oncology group phase II study 8805
69. Long-term survival after concurrent cisplatin/etoposide (PE) plus chest radiotherapy (RT) followed by surgery in bulky, stages IIIA (N2) and IIIB non-small cell lung cancer (NSCLC): 6-Year outcomes from southwest oncology group study 8805
70. Preoperative chemotherapy followed by concurrent chemoradiation therapy based on hyperfractionated accelerated radiotherapy and definitive surgery in locally advanced non-small cell lung cancer: Mature results of a phase II trial
71. Effects of postoperative mediastinal radiation on completely resected stage II and stage III epidermoid cancer of the lung
72. The impact of surgical adjuvant thoracic radiation therapy for patients with nonsmall cell lung carinoma with ipsilateral mediastinal lymph node involvement
73. Adjuvant chemotherapy: Results and perspectives
74. Prospective randomized trial of postoperative adjuvant therapy in patients with completely resected stages II and IIIA non-small cell lung cancer: An intergroup trial (E3590)
75. Adjuvant chemotherapy after complete resection in non-small cell lung cancer
76. Preoperative chemotherapy for stage IIIa (N2) lung cancer: The Sloan-Kettering experience with 136 patients
77. A randomized trial comparing preoperative chemotherapy plus surgery with surgery, alone in patients with non-small-cell lung cancer
78. A randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer
79. Surgical resection of stage IIIA and stage IIIB non-small-cell lung cancer after concurrent induction chemoradiotherapy. A southwest oncology group trial
80. Neoadjuvant therapy: A novel and effective treatment for stage IIIb non-small cell lung cancer